Products for Research Use Only
RegisterLogin

PF-06655075 (TFA)

CAT: 0804-HY-153963ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-153963ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PF-06655075 (TFA) is the TFA form of PF-06655075. PF-06655075 is a novel andnon–brain-penetrant oxytocin receptor agonist with increased selectivity for the oxytocin receptor and significantly increased pharmacokinetic stability. PF-06655075 can be used as a tool compound to further explore the role of peripheral oxytocin in behavioral response[1].
UNSPSC
12352209
Target
Oxytocin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/pf-06655075-tfa.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C(C[C@@H](C(N[C@@H]([C@H](CC)C)C(N[C@H](C(N[C@H]2CC(N)=O)=O)CCC(N)=O)=O)=O)NC([C@@H](N)CSSC[C@@H](C(NCC(N[C@@H](CCCCNC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCCCCCCCCCCCCCC)=O)=O)C(NCC(N)=O)=O)=O)=O)NC2=O)=O)C=C1.O=C(O)C(F)(F)F.[x]
Molecular Formula
C75H130N14O22S2.xC2HF3O2
References & Citations
[1]Meera E, et al. Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing. J Pharmacol Exp Ther. 2016 Aug; 358 (2) : 164–172.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-153963-01PF-06655075
HY-153964APF-06478939 (TFA)
HY-P1300A[ (pF) Phe4]Nociceptin (1-13) NH2 (TFA)
HY-P990649-01PF-5212374
HY-111965-01PF-06647263
HY-10459-01PF-562271
HY-108341-01PF-06424439
HY-100398-01PF-04979064
HY-131972-01PF-06843195
HY-14464-01PF-00489791

Alternative Products

CatalogName
T81501-01PF-06655075 TFA
MBS5820836PF-06478939 TFA
T79172-01PF-06655075
MBS579460PF-03084014 (PF-3084014)
M36412-01PF-17
M34376-01PF-184298
M33060-01PF-04957325
M28021-01PF-1355
M26783-01PF-04937319
M26368-01PF-04885614

Popular Products